Hyperlipidemia
Episodes 1-16 of 37
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie M. Ballantyne, MD, FACP, FACC
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesKausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
Ulrich Laufs, MD, PhD
Pasquale Perrone-Filardi, MD, PhD
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
- MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program creditsProf. Kausik Ray
- MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program creditsProf. Alberto Zambon MD, PhD, FAHA
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Prof. Alberto Zambon MD, PhD, FAHA
Kausik Ray, MBChB, MD, MPhil
Azfar Zaman, MD
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Stephen Nicholls, FRACP, FACC, FESC, FAHA
John Kastelein, MD, PhD
Daniel Gaudet, MD, PhD
Christie M. Ballantyne, MD, FACP, FACC
- Prev
- Next